The mechanism behind the inhibitory effect of isoflurane on angiotensin II-induced vascular contraction is different from that of sevoflurane

Anesthesia and Analgesia

Volumn 105, Issue 1, 2007, Pages 97-102

  Ishikawa, Ai ^a   Ogawa, Koji ^a   Tokinaga, Yasuyuki ^a   Uematsu, Nobuhiko ^a   Mizumoto, Kazuhiro ^a   Hatano, Yoshio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCIUM; ISOFLURANE; PROTEIN KINASE C; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FLUOROMETER; FORCE TRANSDUCER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VASOCONSTRICTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ISOFLURANE; ISOMETRIC CONTRACTION; MALE; METHYL ETHERS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, WISTAR; VASOCONSTRICTION;

EID: 34250803237     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000265851.37923.ec     Document Type: Article

References (21)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-72.
2. Yu J, Ogawa K, Tokinaga Y, Iwahashi S, Hatano Y. The vascular relaxing effects of sevoflurane and isoflurane are more important in hypertensive than normotensive rats. Can J Anesth 2004;51:979-85.
3. 2+- elicited contraction of rat aortic smooth muscle. Anesthesiology 2004;100:879-84.
4. Yu J, Ogawa K, Tokinaga Y, Hatano Y. Sevoflurane inhibits guanosine 5′-[γ-thio] triphosphate-stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle. Anesthesiology 2003;99:646-51.
5. Yu J, Mizumoto K, Tokinaga Y, Ogawa K, Hatano Y. The inhibitory effects of sevoflurane on angiotensin II-induced, p44/42 Mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle. Anesth Analg 2005;101:315-21.
6. Molly CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in aortic smooth muscle cells. J Biol Chem 1993;268:7338-45.
7. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
8. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle: new concepts. Hypertension 1997;29:366-73.
9. 2+, protein kinase C and myosin light chain phosphatase. Jpn Heart J 1996;37:793-813.
10. 2+-independent contraction of vascular smooth muscle. Biochem Cell Biol 1996;74:485-502.
11. Ohanian V, Ohanian J, Shaw L, Scarth S, Parker PJ, Heagerty AM. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction. Circ Res 1996;78:806-12.
12. Damron DS, Nadim HS, Hong SJ, Darvish A, Murray PA. Intracellular translocation of PKC isoforms in canine pulmonary artery smooth muscle cells by ANG II. Am J Physiol 1998;274:L278-L288.
13. 2+ mobilization in aortic smooth muscle cells from hypertensive rats. Anesthesiology 2002;97:642-51.
14. Ishihata A, Tasaki K, Katano Y. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 2002;445:247-56.
15. Yu J, Ogawa K, Tokinaga Y, Mizumoto K, Kakutani T, Hatano Y. The inhibitory effects of isoflurane on protein tyrosine phosphorylation-modulated contraction of rat aortic smooth muscle. Anesthesiology 2004;101:1325-31.
16. Yu J, Mizumoto K, Kakutani T, Hasegawa A, Ogawa K, Hatano Y. Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction. Acta Anaesthesiol Scand 2005;49:852-8.
17. 1 receptors. Hypertens Res 1996;19:201-6.
18. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli JF, Viars P. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994;81:299-307.
19. Meersschaert K, Burn L, Gourdin M, Mouren S, Bertrand M, Riou B, Coriat P. Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective, randomized, double-blinded, crossover study. Anesth Analg 2002;94:835-40.
20. Brabant SM, Bertrand M, Eyraud D, Damron PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999;88:1388-92.
21. Comfere T, Sprung L, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005;100:636-44.